Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>
Xin Yang(National Institutes of Health), Mark E. Robson(Memorial Sloan Kettering Cancer Center), Karin Kast(University Hospital Carl Gustav Carus), Laurent Castéra(Inserm), Lisa Golmard(Université Paris Sciences et Lettres), Judy E. Garber, Ian Jacobs(Royal London Hospital for Integrated Medicine), Allan Jensen(Danish Cancer Society), Jill S. Dolinsky, Helen Hanson(University of Exeter), Fergus J. Couch(WinnMed), Holly LaDuca, Honglin Song(University of Cambridge), Goska Leslie(University of Cambridge), Richard S. Houlston(Institute of Cancer Research), Clare Turnbull(Royal Marsden NHS Foundation Trust), David D.L. Bowtell(Peter MacCallum Cancer Centre), Thomas van Overeem Hansen(Rigshospitalet), Hans Ehrencrona(Lund University), Ana Vega(Complejo Hospitalario Universitario de Santiago), Joe Dennis(University of Cambridge), Estrid Høgdall(University of Copenhagen), Bernd Auber(Medizinische Hochschule Hannover), Adam N. Rosenthal(University College London), Christoph Engel, Åke Borg(Lund University), Susanne K. Kjær(Canadian Institutes of Health Research), Malene Djursby(Copenhagen University Hospital), Ana Osório(Spanish National Cancer Research Centre), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Liisa M. Pelttari(University of Helsinki), Simon A. Gayther(University of Southern California), Susan J. Ramus(University of Southern California), Ed Dicks(Institute of Cancer Research), Heli Nevanlinna(Helsinki University Hospital), Ramūnas Janavičius(Vilnius University), Anders Kvist(Lund University), Eric Hahnen(University Hospital Cologne), Dieter Niederacher(Heinrich Heine University Düsseldorf), Chey Loveday(Institute of Cancer Research), Usha Menon(Queen Mary University of London), Bárbara Rivera(Jewish General Hospital), Judith Balmañà(Vall d'Hebron Hospital Universitari), Andrew Lee(University of Cambridge), Judit Horváth(University Hospital Münster), Stephen B. Gruber(University of Michigan), Kristiina Aittomäki(University of Helsinki), Nadia Traficante(The University of Melbourne), kConFab Investigators, Orland Dı́ez(University of North Carolina at Chapel Hill)
Cited by 163
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k